Peptidylarginine deiminase 3 modulates response to neratinib in HER2 positive breast cancer
Neratinib is a tyrosine kinase inhibitor that is used for the therapy of patients with HER2+ breast tumors. However, despite its clinical benefit, …
Neratinib is a tyrosine kinase inhibitor that is used for the therapy of patients with HER2+ breast tumors. However, despite its clinical benefit, …
One of the fundamental biological characteristics of malignant tumors is their uncontrolled growth and multiplication, which is a major reason why …